Yuichiro Yoshioka

Neoadjuvant Oxaliplatin and Capecitabine and Bevacizumab without Radiotherapy for Poor-risk Rectal Cancer: N-SOG 03 Phase II Trial

Keisuke Uehara, Kazuhiro Hiramatsu, Atsuyuki Maeda et al. · Japanese Journal of Clinical Oncology · 2013 · 144 citations · Full text

SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1

Yuichiro Yoshioka, Takehiro Suzuki, Yo Matsuo et al. · Oncotarget · 2016 · 51 citations · Full text

Critical roles of SMYD2-mediated β-catenin methylation for nuclear translocation and activation of Wnt signaling

Xiaolan Deng, Ryuji Hamamoto, Theodore Vougiouklakis et al. · Oncotarget · 2017 · 43 citations · Full text

Effects of <scp>SMYD</scp>2‐mediated <scp>EML</scp>4‐<scp>ALK</scp> methylation on the signaling pathway and growth in non‐small‐cell lung cancer cells

Rui Wang, Xiaolan Deng, Yuichiro Yoshioka et al. · Cancer Science · 2017 · 40 citations · Full text

“Supraportal” Right Posterior Hepatic Artery: An Anatomic Trap in Hepatobiliary and Transplant Surgery

Yuichiro Yoshioka, Tomoki Ebata, Yukihiro Yokoyama et al. · World Journal of Surgery · 2011 · 39 citations